This is the authors' abstract. We don't add key points for this paper.
1-β-D-Arabinofuranosylcytosine hydrochloride has been shown to be active against recently transplanted and established Sarcoma 180, Ehrlich carcinoma and L-1210 leukemia in mice. This nucleoside was inactive at the same dose per kilogram of body weight in tumor-bearing rats.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Evans et al. (1961) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: